PRMT5 and ovarian carcinoma: Combined with the above observations in our manuscript, we speculate that, on the one hand, high levels of PRMT5 may serve as a biomarker for Taxol resistance in ovarian cancer, and, on the other hand, high expression of PRMT5 may be an important mechanism of cancer cell resistance to Taxol.